Felipe Matsunaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Felipe Matsunaga has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Renyu Liu
Department of Anesthesiology and Critical Care, and Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA
5 shared publications Jin Xi
Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia Pennsylvania
4 shared publicationsJeffery G. Saven
Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania
3 shared publicationsJose Manuel Perez-Aguilar
Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania
3 shared publications- Agata A. Exner
Case Western Reserve University
2 shared publications Bernard Selling
Impact Biologicals Inc., Wallingford, Pennsylvania
2 shared publications
Latest Publications
- Open Access
- 1 January 2027
- Published by KEAI Publishing in Bioactive Materials
- Vol. 67, 344-359
Preclinical evaluation of PSMA-targeted ultrasound contrast agents in an orthotopic model of prostate cancer in rabbits
- 1 January 2027
- Published by KEAI Publishing in Bioactive Materials
- Vol. 67, 344-359
Open AccessPreclinical evaluation of PSMA-targeted ultrasound contrast agents in an orthotopic model of prostate cancer in rabbits
- 11 June 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (11) , 108897
Transarterial Embolization for Pediatric Pelvic Fracture Hemorrhage: A National Trauma Data Bank Analysis (2013–2023)
- 11 June 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (11) , 108897
Transarterial Embolization for Pediatric Pelvic Fracture Hemorrhage: A National Trauma Data Bank Analysis (2013–2023)
- Open Access
Preclinical Evaluation of PSMA-Targeted Ultrasound Contrast Agents in an Orthotopic Model of Prostate Cancer in Rabbits
The localization of prostate cancer by ultrasound remains limited by the lack of B-mode conspicuity and the confinement of clinically approved microbubbles (MBs) to the vasculature. This precludes the differentiation of viable tumor tissue, necrotic tissue, and margin-associated disease. We investigate the use of prostate-specific membrane antigen (PSMA)-targeted lipid-shelled perfluorocarbon nanobubbles (PSMA-NBs) in an orthotopic rabbit model using a clinical CEUS system. We implanted PSMA-positive PC3pip-GFP tumors into the prostates of immunosuppressed New Zealand White rabbits and performed transabdominal imaging with PSMA-NBs, MBs, and untargeted nanobubbles (Plain-NB) using the same imaging and analysis protocols. To address tumor heterogeneity and ultrasound boundary ambiguity, ROIs were defined from baseline B-mode images and segmented into the tumor core, rim, and a surrounding peritumoral area. Pixel-wise parametric and decorrelation time (DT) maps were generated and correlated with whole-slide histology (H&E) and PSMA IHC. Compared to MBs, PSMA-NBs exhibited higher peak intensities in the tumor core and rim (1.60-fold and 1.50-fold, respectively) and improved retention (mean transit time: 4.20 to 4.50-fold higher) for up to 10 minutes in the tumor and peritumoral areas. PSMA-NB kinetic and DT parameters also correlated with histology-defined tumor viability and PSMA expression. Compared to Plain-NBs, PSMA-NBs also exhibited improved retention (MTT +21%; AUCwo) in the rim and peritumoral areas. This study demonstrates the capability of PSMA-NBs to characterize prostate cancer by molecular CEUS beyond what is possible with conventional MBs.
Open AccessPreclinical Evaluation of PSMA-Targeted Ultrasound Contrast Agents in an Orthotopic Model of Prostate Cancer in Rabbits
The localization of prostate cancer by ultrasound remains limited by the lack of B-mode conspicuity and the confinement of clinically approved microbubbles (MBs) to the vasculature. This precludes the differentiation of viable tumor tissue, necrotic tissue, and margin-associated disease. We investigate the use of prostate-specific membrane antigen (PSMA)-targeted lipid-shelled perfluorocarbon nanobubbles (PSMA-NBs) in an orthotopic rabbit model using a clinical CEUS system. We implanted PSMA-positive PC3pip-GFP tumors into the prostates of immunosuppressed New Zealand White rabbits and performed transabdominal imaging with PSMA-NBs, MBs, and untargeted nanobubbles (Plain-NB) using the same imaging and analysis protocols. To address tumor heterogeneity and ultrasound boundary ambiguity, ROIs were defined from baseline B-mode images and segmented into the tumor core, rim, and a surrounding peritumoral area. Pixel-wise parametric and decorrelation time (DT) maps were generated and correlated with whole-slide histology (H&E) and PSMA IHC. Compared to MBs, PSMA-NBs exhibited higher peak intensities in the tumor core and rim (1.60-fold and 1.50-fold, respectively) and improved retention (mean transit time: 4.20 to 4.50-fold higher) for up to 10 minutes in the tumor and peritumoral areas. PSMA-NB kinetic and DT parameters also correlated with histology-defined tumor viability and PSMA expression. Compared to Plain-NBs, PSMA-NBs also exhibited improved retention (MTT +21%; AUCwo) in the rim and peritumoral areas. This study demonstrates the capability of PSMA-NBs to characterize prostate cancer by molecular CEUS beyond what is possible with conventional MBs.
- 18 February 2022
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (4) , 1505-1506
Aortic cobweb sign
- 18 February 2022
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (4) , 1505-1506
Aortic cobweb sign
- 1 June 2021
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 216 (6) , 1452-1461
Systematic Review of the Management of Ureteroarterial Fistulas After Ileal Conduit Urinary Diversion
OBJECTIVE. No studies or guidelines exist to direct management of ureteroarterial fistula (UAF) after ileal conduit urinary diversion in which the possible risks and complications associated with stent-graft infection from the conduit flora must be reconciled with those of open surgical repair. This study seeks to characterize the clinical presentation, pathogenesis, and optimal diagnostic and therapeutic management of this entity through a systematic review of the literature. MATERIALS AND METHODS. A systematic search of the English-language literature using the PubMed, Scopus, and ScienceDirect databases was performed: 264 abstracts were identified. From those abstracts, 32 studies comprising 40 patients with 43 UAFs were selected for analysis. Data points including demographics, clinical presentation, UAF specifications, procedural details, postprocedural complications, and clinical outcomes were reviewed. RESULTS. Predisposing factors included female sex, chronic ureteral stent placement, and past surgical intervention and irradiation for pelvic malignancy. Fistulization was overwhelmingly unilateral (95.0% of patients) and included the common iliac artery (90.7% of UAFs). Combined endovascular and endoureteral modalities presented similar outcomes compared with surgical approaches in terms of UAF-related mortality (7.1% vs 13.3%, respectively) and complication rates (28.6% vs 26.7%) during a similar median follow-up period (9.5 vs 14.0 months). Endovascular stent-graft infections were present in 14.3% of cases and represented a leading indication for reintervention after endovascular management (50.0%). CONCLUSION. Short- and intermediate-term outcomes of combined endovascular and endoureteral techniques compare favorably with those of surgical approaches in the treatment of UAF after ileal conduit urinary diversion. Although there is a relatively low stent-graft infection rate, close follow-up within the first year after the procedure is required given the propensity of complications to develop during this window. The use of postprocedural antibiotics is uncertain but is likely prudent.
- 1 June 2021
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 216 (6) , 1452-1461
Systematic Review of the Management of Ureteroarterial Fistulas After Ileal Conduit Urinary Diversion
OBJECTIVE. No studies or guidelines exist to direct management of ureteroarterial fistula (UAF) after ileal conduit urinary diversion in which the possible risks and complications associated with stent-graft infection from the conduit flora must be reconciled with those of open surgical repair. This study seeks to characterize the clinical presentation, pathogenesis, and optimal diagnostic and therapeutic management of this entity through a systematic review of the literature. MATERIALS AND METHODS. A systematic search of the English-language literature using the PubMed, Scopus, and ScienceDirect databases was performed: 264 abstracts were identified. From those abstracts, 32 studies comprising 40 patients with 43 UAFs were selected for analysis. Data points including demographics, clinical presentation, UAF specifications, procedural details, postprocedural complications, and clinical outcomes were reviewed. RESULTS. Predisposing factors included female sex, chronic ureteral stent placement, and past surgical intervention and irradiation for pelvic malignancy. Fistulization was overwhelmingly unilateral (95.0% of patients) and included the common iliac artery (90.7% of UAFs). Combined endovascular and endoureteral modalities presented similar outcomes compared with surgical approaches in terms of UAF-related mortality (7.1% vs 13.3%, respectively) and complication rates (28.6% vs 26.7%) during a similar median follow-up period (9.5 vs 14.0 months). Endovascular stent-graft infections were present in 14.3% of cases and represented a leading indication for reintervention after endovascular management (50.0%). CONCLUSION. Short- and intermediate-term outcomes of combined endovascular and endoureteral techniques compare favorably with those of surgical approaches in the treatment of UAF after ileal conduit urinary diversion. Although there is a relatively low stent-graft infection rate, close follow-up within the first year after the procedure is required given the propensity of complications to develop during this window. The use of postprocedural antibiotics is uncertain but is likely prudent.
- 1 January 2021
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 16 (5) , 1369-1370
Primary synovial sarcoma of the heart
- 1 January 2021
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 16 (5) , 1369-1370
Primary synovial sarcoma of the heart
- 17 September 2020
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (3) , 1278-1279
Spalding sign
- 17 September 2020
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (3) , 1278-1279
Spalding sign
- 18 July 2020
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 16 (2) , 497-499
Rapidly destructive osteoarthritis of the hip
- 18 July 2020
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 16 (2) , 497-499
Rapidly destructive osteoarthritis of the hip
- Open Access
- 1 March 2020
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 31 (3) , S277
Abstract No. 639 Procedural sedation for interventional radiology procedures: a 10-year analysis of large health care database
- 1 March 2020
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 31 (3) , S277
Open AccessAbstract No. 639 Procedural sedation for interventional radiology procedures: a 10-year analysis of large health care database